ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CERT Certara Inc

16.45
0.00 (0.00%)
Pre Market
Last Updated: 04:05:20
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Certara Inc CERT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 16.45 04:05:20
Open Price Low Price High Price Close Price Prev Close
16.45
more quote information »

Recent News

Date Time Source Heading
4/16/202408:00GLOBECertara Launches Cloud Platform to Further Unify its..
4/09/202416:15GLOBECertara to Report First Quarter 2024 Financial Results on..
3/06/202416:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202419:26EDGAR2Form 144 - Report of proposed sale of securities
2/29/202416:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/29/202416:21EDGAR2Form 8-K - Current report
2/29/202416:10GLOBECertara Reports Fourth Quarter 2023 Financial Results
2/21/202416:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202412:25EDGAR2Form 144 - Report of proposed sale of securities
2/14/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202417:14EDGAR2Form 144 - Report of proposed sale of securities
2/01/202416:30GLOBECertara to Report Fourth Quarter and Full Year 2023..
12/27/202318:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/26/202312:22EDGAR2Form 144 - Report of proposed sale of securities
12/13/202316:30GLOBECertara Acquires Applied BioMath Expanding Its Biosimulation..
11/21/202316:30GLOBECertara introduces Simcyp™ Biopharmaceutics software to..
11/08/202316:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202316:16EDGAR2Form 8-K - Current report
11/08/202316:10GLOBECertara Reports Third Quarter 2023 Financial Results
10/11/202316:15GLOBECertara to Report Third Quarter 2023 Financial Results on..
10/06/202317:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/19/202308:15GLOBECertara Announces 300th Regulatory Submission Milestone..
8/29/202316:15GLOBECertara to Participate in Upcoming Investor Conferences
8/29/202308:15GLOBECertara Simcyp™ Group Awarded Two New Grants from US FDA
8/09/202316:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202316:15GLOBECertara Reports Second Quarter 2023 Financial Results
8/09/202316:11EDGAR2Form 8-K - Current report
8/03/202321:00BWCertara collaborates with Korea Institute of Toxicology to..
8/02/202316:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/13/202316:30GLOBECertara to Report Second Quarter 2023 Financial Results on..
7/03/202317:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/02/202316:15GLOBECertara to Participate in the Jefferies Global Healthcare..
5/08/202316:15GLOBECertara Reports First Quarter 2023 Financial Results
4/27/202308:00GLOBECertara Customers Received 90 Percent of US FDA Novel Drug..

Your Recent History

Delayed Upgrade Clock